Israel Krieger1, Dana Tzur Bitan2, Doron Comaneshter3, Arnon Cohen4, Daniel Feingold5. 1. Shalvata Mental Health Center, Affiliated with the Sackler School of Medicine, Tel Aviv University, Aliat Hanoar 13, Hod Hasharon, Israel. 2. Department of Behavioral Sciences, Ariel University, 40700, Israel; Shalvata Mental Health Center, Affiliated with the Sackler School of Medicine, Tel Aviv University, Aliat Hanoar 13, Hod Hasharon, Israel. Electronic address: danatz@ariel.ac.il. 3. Chief Physician's Office, Clalit Health Services, Dov Hos 1, Tel Aviv, Israel. 4. Chief Physician's Office, Clalit Health Services, Dov Hos 1, Tel Aviv, Israel; Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel. 5. Department of Behavioral Sciences, Ariel University, 40700, Israel.
Abstract
BACKGROUND: Schizophrenia patients smoke at three times the rate of the general population, and are more susceptible to smoking-related illnesses. The goal of the current study was to evaluate the cumulative probability of chronic obstructive pulmonary disease (COPD) and ischemic heart disease (IHD) following first documentation of smoking among schizophrenia patients as compared to smoking healthy controls. METHODS: A nationally representative cohort study was designed to assess the odds and cumulative probability of COPD and IHD among individuals with schizophrenia (n = 10,502) and a matched-sample of smoking healthy controls (n = 10,502). Hierarchical logistic regressions and Kaplan-Meier regression models were used to compare odds and cumulative probabilities across the two groups. RESULTS: After adjusting for clinical and demographic factors, smoking schizophrenia patients had a higher probability of receiving a diagnosis of COPD than smoking healthy controls (OR 2.14, 95%CI 1.51-3.01, p < 0.001). The probability of having COPD increased more rapidly in smoking schizophrenia patients, yet the opposite trajectory prevailed for IHD, showing a decreased cumulative probability in smoking schizophrenia patients compared to smoking healthy controls. DISCUSSION: Schizophrenia has a unique contribution to the facilitation of COPD, which extends beyond the effect of smoking, or other clinical and demographic risk factors. Differential smoking patterns could potentially account for this effect. The differential pattern of IHD should be subjected to further research, as our results might indicate that schizophrenia patients are underdiagnosed with IHD, and may be even less diagnosed as a function of time and chronicity.
BACKGROUND:Schizophreniapatients smoke at three times the rate of the general population, and are more susceptible to smoking-related illnesses. The goal of the current study was to evaluate the cumulative probability of chronic obstructive pulmonary disease (COPD) and ischemic heart disease (IHD) following first documentation of smoking among schizophreniapatients as compared to smoking healthy controls. METHODS: A nationally representative cohort study was designed to assess the odds and cumulative probability of COPD and IHD among individuals with schizophrenia (n = 10,502) and a matched-sample of smoking healthy controls (n = 10,502). Hierarchical logistic regressions and Kaplan-Meier regression models were used to compare odds and cumulative probabilities across the two groups. RESULTS: After adjusting for clinical and demographic factors, smoking schizophreniapatients had a higher probability of receiving a diagnosis of COPD than smoking healthy controls (OR 2.14, 95%CI 1.51-3.01, p < 0.001). The probability of having COPD increased more rapidly in smoking schizophreniapatients, yet the opposite trajectory prevailed for IHD, showing a decreased cumulative probability in smoking schizophreniapatients compared to smoking healthy controls. DISCUSSION: Schizophrenia has a unique contribution to the facilitation of COPD, which extends beyond the effect of smoking, or other clinical and demographic risk factors. Differential smoking patterns could potentially account for this effect. The differential pattern of IHD should be subjected to further research, as our results might indicate that schizophreniapatients are underdiagnosed with IHD, and may be even less diagnosed as a function of time and chronicity.
Authors: M J Jaen-Moreno; N Feu; G I Del Pozo; C Gómez; L Carrión; G M Chauca; I Guler; F J Montiel; M D Sánchez; J A Alcalá; L Gutierrez-Rojas; V Molina; J Bobes; V Balanzá-Martínez; C Ruiz-Rull; F Sarramea Journal: Eur Psychiatry Date: 2021-02-26 Impact factor: 5.361
Authors: Gabriel G Edwards; Audrey Uy-Evanado; Eric C Stecker; Angelo Salvucci; Jonathan Jui; Sumeet S Chugh; Kyndaron Reinier Journal: Int J Cardiol Heart Vasc Date: 2022-04-08